Intelligence Platform
Patents
Browse 19 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 9220692
Methods of reducing symptoms in subjects using single dosage forms with tapering release r
granted patentUS 8980304
Barrel-shaped vaginal ring
granted patentUS 8680084
Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
granted patentUS 8663681
Oral dosage forms comprising progesterone and methods of making and using the same
granted patentUS 8580293
Monolithic intravaginal rings comprising progesterone and methods of making and uses there
granted patentUS 8338396
Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
granted patentUS 8323679
Flexible, compressed intravaginal rings, methods of making and using the same, and apparat
granted patentUS 8288342
Methods for treating vasomotor symptoms in castrated prostatic cancer patients with low do
granted patentUS 8247393
Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof
granted patentUS 8226980
Orally disintegrating solid dosage forms comprising progestin and methods of making and us
granted patentUS 8217024
Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof
granted patentUS 8202534
Attachment of a handle to a solid oral dosage form
granted patentUS 8148560
Vaginal tablets comprising misoprostol and methods of making and using the same
granted patentUS 7910126
Flexible, compressed intravaginal rings, methods of making and using the same, and apparat
granted patentUS 7908729
Method for making a lollipop
granted patentUS 7858605
Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
granted patentUS 7855190
Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen ad
granted patentUS 7784616
Dispenser for progestin used for acute maintenance treatment of DUB
granted patentUS 7772219
Methods of hormonal treatment utilizing extended cycle contraceptive regimens
granted